[1] |
CAVALIERE M, BISOGNO A, SCARPA A, et al. Biomarkers of laryngeal squamous cell carcinoma:a review[J]. Ann Diagn Pathol, 2021,54:151787. doi:10.1016/j.anndiagpath.2021.151787.
|
[2] |
BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3):229-263. doi:10.3322/caac.21834.
|
[3] |
NOCINI R, MOLTENI G, MATTIUZZI C, et al. Updates on larynx cancer epidemiology[J]. Chin J Cancer Res, 2020, 32(1):18-25. doi:10.21147/j.issn.1000-9604.2020.01.03.
|
[4] |
BARSOUK A, ALURU J S, RAWLA P, et al. Epidemiology,risk factors,and prevention of head and neck squamous cell carcinoma[J]. Med Sci (Basel), 2023, 11(2):42-46. doi:10.3390/medsci11020042.
|
[5] |
JOHNSON D E, BURTNESS B, LEEMANS C R, et al. Head and neck squamous cell carcinoma[J]. Nat Rev Dis Primers, 2020, 6(1):92. doi:10.1038/s41572-020-00224-3.
|
[6] |
杨雪竹, 张浩, 崔西玉, 等. 川陈皮素抑制胃癌SGC-7901细胞侵袭能力的机制探讨[J]. 现代肿瘤医学, 2020, 28(18):3099-3104.
|
|
YANG X Z, ZHANG H, CUI X Y, et al. Study on the mechanism of nobiletin inhibiting the invasiveness of SGC-7901 gastric cancer cells[J]. J Mod Oncol, 2020, 28(18):3099-3104. doi:10.3969/j.issn.1672-4992.2020.18.001.
|
[7] |
张阳, 姜华茂. 川陈皮素对人前列腺癌DU145细胞生长的抑制作用及其机制[J]. 吉林大学学报(医学版), 2020, 46(6):1260-1266.
|
|
ZHANG Y, JIANG H M. Inhibitory effect of nobiletin on growth of human prostate cancer DU145 cells and its mechanism[J]. J Jilin Univ(Med Ed), 2020, 46(6):1260-1266. doi:10.13481/j.1671-587x.20200624.
|
[8] |
ROSAS-MARTÍNEZ M, GONZÁLEZ ROSALES J A, GUTIÉRREZ-VENEGAS G. Nobiletin regulates invasion,migration and metastasis in hypopharyngeal squamous cell carcinoma[J]. Cell Mol Biol (Noisy-le-grand), 2023, 69(7):1-6. doi:10.14715/cmb/2023.69.7.1.
|
[9] |
WANG R, WANG S, LI Z, et al. PLEKHH2 binds β-arrestin1 through its FERM domain,activates FAK/PI3K/AKT phosphorylation,and promotes the malignant phenotype of non-small cell lung cancer[J]. Cell Death Dis, 2022, 13(10):858. doi:10.1038/s41419-022-05307-5.
|
[10] |
XU Z, LI H, LIN C, et al. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway[J]. J Bioenerg Biomembr, 2021, 53(2):203-211. doi:10.1007/s10863-021-09871-x.
|
[11] |
陈晓, 谢涵. 川陈皮素调节TLR4/TRIF/IRF3信号通路对宫颈癌细胞增殖、凋亡和侵袭的影响[J]. 中国优生与遗传杂志, 2022, 30(8):1305-1311.
|
|
CHEN X, XIE H. Effects of Nobiletin on the proliferation,apoptosis and invasion of cervical cancer cells by regulating TLR4/TRIF/IRF3 signaling pathway[J]. Chinese Journal of Birth Health & Heredity, 2022, 30(8):1305-1311. doi:10.13404/j.cnki.cjbhh.2022.08.038.
|
[12] |
WANG Q, GALLARDO-MACIAS R, RASHMI, et al. Discovery of novel small-molecule FAK activators promoting mucosal healing[J]. ACS Med Chem Lett, 2021, 12(3):356-364. doi:10.1021/acsmedchemlett.0c00311.
|
[13] |
MATTIOLI F, FERMI M, MOLINARI G, et al. pT3 N0 laryngeal squamous cell carcinoma:oncologic outcomes and prognostic factors of surgically treated patients[J]. Laryngoscope, 2021, 131(10):2262-2268. doi:10.1002/lary.29528.
|
[14] |
AL-HAKAMI H A, AL GARNI M A, ALSUBAYEA H, et al. The incidence of thyroid gland invasion in advanced laryngeal squamous cell carcinoma[J]. Braz J Otorhinolaryngol, 2021, 87(5):533-537. doi:10.1016/j.bjorl.2019.11.003.
|
[15] |
周晓红, 杨雪, 连蕾, 等. 白芍总苷对喉癌Hep-2细胞增殖、侵袭、迁移及PI3K/Akt/GSK3β信号通路的影响[J]. 标记免疫分析与临床, 2022, 29(2):236-241.
|
|
ZHOU X H, YANG X, LIAN L, et al. Effects of total glucosides of paeony on proliferation,invasion,migration and PI3K/Akt/GSK3β signaling pathway of laryngeal cancer Hep-2 cells[J]. Labeled Immunoassays & Clin Med, 2022, 29(2):236-241. doi:10.11748/bjmy.issn.1006-1703.2022.02.012.
|
[16] |
CHEN Y Y, LIANG J J, WANG D L, et al. Nobiletin as a chemopreventive natural product against cancer,a comprehensive review[J]. Crit Rev Food Sci Nutr, 2023, 63(23):6309-6329. doi:10.1080/10408398.2022.2030297.
|
[17] |
JIANG H, CHEN H, JIN C, et al. Nobiletin flavone inhibits the growth and metastasis of human pancreatic cancer cells via induction of autophagy,G0/G1 cell cycle arrest and inhibition of NF-κB signalling pathway[J]. J BUON, 2020, 25(2):1070-1075.
|
[18] |
WU Y, LI Q, LV L L, et al. Nobiletin inhibits breast cancer cell migration and invasion by suppressing the IL-6-induced ERK-STAT and JNK-c-JUN pathways[J]. Phytomedicine, 2023,110:154610. doi:10.1016/j.phymed.2022.154610.
|
[19] |
芮翊馨, 谢红潇, 李丹, 等. 中乌宁通过BAX/BCL-2/Caspase 3信号通路抑制细胞凋亡改善慢性肾衰竭大鼠肾纤维化[J]. 中药药理与临床, 2024, 40(5):42-48.
|
|
RUI Y X, XIE H X, LI D, et al. Mesaconine inhibits apoptosis through the BAX /BCL-2 /Caspase 3 signaling pathway to improve renal fibrosis in rats with chronic renal failure[J]. Pharmacol Clin Chin Mater Med, 2024, 40(5):42-48. doi:10.13412/j.cnki.zyyl.20231117.003.
|
[20] |
BULGURCUOGLU KURAN S, ALTUN A, KARAMUSTAFAOGLU BALCI B, et al. Expression of pro-apoptotic and anti-apoptotic proteins in granulosa cells of women with diminished ovarian reserve[J]. J Assist Reprod Genet, 2022, 39(3):765-775. doi:10.1007/s10815-022-02422-2.
|
[21] |
HU L, DUAN Y T, LI J F, et al. Biglycan enhances gastric cancer invasion by activating FAK signaling pathway[J]. Oncotarget, 2014, 5(7):1885-1896. doi:10.18632/oncotarget.1871.
|
[22] |
DU J, FU L, HAO J, et al. Rab11a is overexpressed in gastric cancer and regulates FAK/AKT signaling[J]. J Oncol, 2020,2020:3494396. doi:10.1155/2020/3494396.
|
[23] |
徐加志, 张芸, 陈大刚, 等. 咖啡因通过FAK/AKT/ROCK通路调控人脑胶质瘤U-373MG细胞的恶性生物学行为[J]. 中国肿瘤生物治疗杂志, 2024, 31(6):573-578.
|
|
XU J Z, ZHNAG Y, CHEN D G, et al. Caffeine modulates the malignant biological behaviors of human brain glioma U-373MG cells by regulating the FAK/AKT/ROCK pathway[J]. Chin J Cancer Biother, 2024, 31(6):573-578. doi:10.3872/j.issn.1007-385x.2024.06.005.
|
[24] |
江小霞, 方燕玲, 李仲均. 褪黑素通过抑制FGA调节FAK/AKT/MMP-2通路对人子宫内膜间质细胞的作用研究[J]. 徐州医科大学学报, 2021, 41(12):865-872.
|
|
JIANG X X, FANG Y L, LI Z J. Effect of melatonin on human endometrial stromal cells by inhibiting FGA to regulate the FAK/AKT/MMP-2 pathway[J]. J Xuzhou Med Univ, 2021, 41(12):865-872. doi:10.3969/j.issn.2096-3882.2021.12.002.
|
[25] |
吴娜萍, 张磊, 方琦, 等. IGSF10通过抑制FAK/PI3K/AKT信号通路降低右美托咪定对乳腺癌促进作用的研究[J]. 中华肿瘤防治杂志, 2022, 29(14):1052-1061.
|
|
WU N P, ZHANG L, FANG Q, et al. IGSF10 reduces dexmedetomidine promotion in breast cancer by inhibiting FAK/PI3K/AKT signaling pathway[J]. Chin J Cancer Prev Treat, 2022, 29(14):1052-1061. doi:10.16073/j.cnki.cjcpt.2022.14.06.
|